相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Early outcomes of migraine after erenumab discontinuation: data from a real-life setting
Eleonora De Matteis et al.
NEUROLOGICAL SCIENCES (2021)
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Mark E. Bangs et al.
BMC NEUROLOGY (2020)
One-year sustained efficacy of erenumab in episodic migraine Results of the STRIVE study
Peter J. Goadsby et al.
NEUROLOGY (2020)
Long-term safety, tolerability, and efficacy of fremanezumab in migraine A randomized study
Peter J. Goadsby et al.
NEUROLOGY (2020)
Discovery of CGRP in relation to migraine
Lars Edvinsson et al.
CEPHALALGIA (2019)
Primary headaches during lifespan
Andreas Straube et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
Messoud Ashina et al.
CEPHALALGIA (2019)
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper et al.
LANCET NEUROLOGY (2017)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey
Andrew Messali et al.
HEADACHE (2016)
The triggers or precipitants of the acute migraine attack
L. Kelman
CEPHALALGIA (2007)
分享论文
